Skip to main content
Clinical Trials/EUCTR2013-001447-31-GB
EUCTR2013-001447-31-GB
Active, not recruiting
Phase 1

A randomised controlled trial to study the effect of acetazolamide on the incidence of blood-stained CSF, effect on cerebrospinal fluid (CSF) pressure, CSF drainage and neurological dysfunction in patients undergoing thoracic-abdominal aortic intervention. - Acetazolamide in aortic surgery

iverpool Heart and Chest Hospital NHS Foundation Trust0 sites60 target enrollmentOctober 29, 2013
DrugsDiamox

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
iverpool Heart and Chest Hospital NHS Foundation Trust
Enrollment
60
Status
Active, not recruiting
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 29, 2013
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
iverpool Heart and Chest Hospital NHS Foundation Trust

Eligibility Criteria

Inclusion Criteria

  • \- Elective patients who have given consent and are 18\+ years
  • \- Patients able to comply with the pre\-operative course of acetazolamide treatment (treatment group) and who have had a blood sample collected at least three days prior to surgery
  • Are the trial subjects under 18? no
  • Number of subjects for this age range: 0
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range 40
  • F.1\.3 Elderly (\>\=65 years) yes
  • F.1\.3\.1 Number of subjects for this age range 20

Exclusion Criteria

  • \- Non\-elective patients, who were not able to participate in pre\-operative acetazolamide treatment and blood sample tests three days prior to surgery
  • \- Patients without consent
  • \- Patients under the age of 18
  • \- Patients unable to independently comprehend and complete the consent form
  • \- Patients unable to independently comply to the pre\-operative course of acetazolamide treatment

Outcomes

Primary Outcomes

Not specified

Similar Trials